RichardRobbinsMD

PubMed

• Persistent or Recurrent Disease in Thyroid Cancer Survivors Who Have Elevated Serum Antithyroglobulin Antibodies.
  Richard J Robbins, Trisha D Cubb, Maleeha Zahid, Jiaqiong Xu> ;Endocrine Practice. 2023 Jun 1
• MEN1 in a Patient With Nonsyndromic Familial Nonmedullary Thyroid Carcinoma.
  Lauren A Fitzgerald, Shelley Williamson, Jawairia Shakil, Robbins, R.> ;JCEM Case Reports. 2023 Jan 1
• Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature.
  Elizabeth Jasola Omoniyi, Richard J Robbins> ;Case Reports in Endocrinology. 2022 Jan 1
• Voices for Social Justice and Against Racism: An AAIM Perspective
  Patricia W. Finn, E. Dale Abel, Alpesh Amin, Mark E. Anderson, John M. Carethers, David L. Coleman, Anne B. Curtis, Mark W. Geraci, Mark T. Gladwin, Anthony N. Hollenb...> ;The American Journal of Medicine. 2021 Apr 10
• Clinical Features in Differentiated Thyroid Carcinoma Stratified By Lymph Node Status.
  Jawairia Shakil, Trisha Cubb, Ahmad Yehya, Ashkan Zand, Jaiqiong Xu, Richard J. Robbins> ;Endocrine Practice. 2020 Aug 1
• 1 citations
  Features of Multiple Endocrine Neoplasia Type 1 and 2A in a Patient With Both RET and MEN1 Germline Mutations
  Spandana Brown, Daniel L. Riconda, Feibi Zheng, Gilchrist L Jackson, Liye Suo, Richard J. Robbins> ;Journal of the Endocrine Society. 2020 Apr 1
• Academic Hospitalists and Health Care Costs.
  Richard J. Robbins, Jose A. Perez, Melina Awar, Johanna Marietta Clewing> ;The American Journal of Medicine. 2019 Jul 1
• 3 citations
  Update on Management of Type 2 Diabetes for Cardiologists
  Mohammed Qureshi, Emily Gammoh, Jawairia Shakil, Richard J. Robbins> ;Methodist Debakey Cardiovascular Journal. 2018 Oct 1
• 15 citations
  PANCREAS METASTASES FROM PAPILLARY THYROID CARCINOMA: A REVIEW OF THE LITERATURE.
  Maja Davidson, Randall J. Olsen, April A. Ewton, Richard J. Robbins> ;Endocrine Practice. 2017 Nov 16
• 41 citations
  Testosterone and the Heart.
  Travis Goodale, Archana R. Sadhu, Steven M. Petak, Richard J. Robbins> ;Methodist Debakey Cardiovascular Journal. 2017 Apr 1
• Guest Editors Richard Robbins and Steven Petak Provide Oversight & Expertise for Special Issue on Hormones and the Heart.
  Richard J. Robbins, Steven M. Petak> ;Methodist Debakey Cardiovascular Journal. 2017 Apr 1
• 23 citations
  Cardiovascular Disease in Acromegaly.
  Morali D Sharma, Anh V Nguyen, Spandana Brown, Richard J. Robbins> ;Methodist Debakey Cardiovascular Journal. 2017 Apr 1
• Hormones and the Heart.
  Richard J. Robbins, Steven M. Petak> ;Methodist Debakey Cardiovascular Journal. 2017 Apr 1
• 8 citations
  LOWER RATES OF RESIDUAL/RECURRENT DISEASE IN PATIENTS WITH INCIDENTALLY DISCOVERED THYROID CARCINOMA
  Jawairia Shakil, Mohammed Z Ansari, Jett R. Brady, Jiaqiong Xu, Richard J. Robbins> ;Endocrine Practice. 2017 Feb 1
• 3 citations
  Hürthle cell carcinoma of the thyroid presenting as thyrotoxicosis.
  Harsha Karanchi, Dale J. Hamilton, Richard J. Robbins> ;Endocrine Practice. 2012 Jan 1
• 59 citations
  Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Reco...
  Hernán Tala, Richard J. Robbins, James A. Fagin, Steven M. Larson, R. M. Tuttle> ;The Journal of Clinical Endocrinology and Metabolism. 2011 May 11
• 11 citations
  The Cardiovascular Effects of Hyperthyroidism
  Lara A. Nabbout, Richard J. Robbins> ;Methodist Debakey Cardiovascular Journal. 2010 Apr 1
• 24 citations
  The value of positron emission tomography (PET) in the management of patients with thyroid cancer
  Richard J. Robbins, Steven M. Larson> ;Best Practice & Research. Clinical Endocrinology & Metabolism. 2008 Dec 1
• 18 citations
  Expanding Indications for Recombinant Human TSH in Thyroid Cancer
  Bryan R. Haugen, David S. Cooper, Charles H. Emerson, Markus Luster, Rui M. B. Maciel, Rosa Paula M. Biscolla, Ernest L. Mazzaferri, Geraldo Medeiros-Neto, Christoph R...> ;Thyroid. 2008 Jul 1
• 101 citations
  Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdr...
  R. Michael Tuttle, Matvey Brokhin, Gal Omry, Andrew J. Martorella, Steven M. Larson, Ravinder K. Grewal, Martin Fleisher, Richard J. Robbins> ;Journal of Nuclear Medicine. 2008 May 1
• 75 citations
  A Sequence-specific Exopeptidase Activity Test (SSEAT) for “Functional” Biomarker Discovery
  Josep Villanueva, Arpi Nazarian, Kevin Lawlor, San San Yi, Richard J. Robbins, Paul Tempst> ;Molecular & Cellular Proteomics. 2008 Mar 1
• 21 citations
  Re: Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
  Darren R. Feldman, Andrew J. Martorella, Richard J. Robbins, Robert J. Motzer> ;Journal of the National Cancer Institute. 2007 Jun 20
• 7 citations
  Serum peptide profiling: identifying novel cancer biomarkers for early disease detection
  Andrew J. Martorella, Richard J. Robbins> ;Acta Bio-Medica. 2007 Mar 1
• 43 citations
  Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn fro...
  Richard J. Robbins, Albert A. Driedger, James A. Magner> ;Thyroid. 2006 Nov 1
• 129 citations
  Empiric Radioactive Iodine Dosing Regimens Frequently Exceed Maximum Tolerated Activity Levels in Elderly Patients with Thyroid Cancer
  R. Michael Tuttle, Rebecca Leboeuf, Richard J. Robbins, Rebecca Qualey, Keith S. Pentlow, Steven M. Larson, Chee Y. Chan> ;Journal of Nuclear Medicine. 2006 Oct 1
• Join now to see all

Journal Articles

• The Costs of Training Internal Medicine Residents in the US  
  Ben-Ari R, Pindiprolu S, Goldman A, Parsons PE., Amer. J. Med., 1/1/2014
• Five Year Survival Is Similar In Thyroid Cancer Patients With Distant Metastases Prepared For Radioactive Iodine Therapy With Either Thyroid Hormone Withdrawal Or Reco...  
  Tala H, Fagin J, Larson SM, Tuttle RM, J Clin Endo Metab., 1/1/2011
• Hürthle Cell Carcinoma of the Thyroid presenting as thyrotoxicosis  
  Karanchi H, Hamilton DJ, Endo. Pract, 1/1/2011
• Perspective- New Guidelines for Thyroid Disease in Pregnancy  
  Robbins RJ, Endocrine Today, 1/1/2011
• The Cardiovascular Effects Of Hyperthyroidism  
  with Nabbout LA, Methodist Debakey Cardiovasc J, 1/1/2010
• Reply: A New Age for Recombinant Human Thyroid-Stimulating Hormone?  
  Tuttle RM, Brokhin M, Larson SM, Journal of Nuclear Medicine, 1/1/2009
• A Sequence-Specific Exopeptidase Activity Test (SSEAT) For "Functional" Biomarker Discovery  
  Villanueva J, Nazarian A, Lawlor K, Yi SS, Tempst P, Mol Cell Proteomics, 1/1/2008
• Recombinant Human TSH-Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdr...  
  Tuttle RM, Brokhin M, Omry G, Martorella AJ, Larson SM, Grewal RK, Fleisher M, J Nucl Med, 1/1/2008
• The Value Of Positron Emission Tomography In The Management Of Patients With Thyroid Cancer  
  with Larson SM, Best Prac. Res. Clin. Endo. Metab., 1/1/2008
• Expanding Indications For Recombinant Human TSH In Thyroid Cancer  
  Haugen BR, Cooper DS, Emerson CH, Luster M, Maciel RM, Biscolla RP, Mazzaferri EL, Medeiros-Neto G, Reiners C, Robinson BG, Schlumberger M, Yamashita S, Pacini F, Thyroid, 1/1/2008
• Serum Peptide Profiling: Identifying Novel Cancer Biomarkers For Early Disease Detection  
  with Martorella A, Acta Biomed, 1/1/2007
• Hypothyroidism In Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib  
  Feldman DR, Martorella AJ, Motzer R, J Natl Cancer Inst, 1/1/2007
• Real-time prognosis of metastatic thyroid carcinoma patients based on FDG-PET scanning  
  Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW, Tuttle RM, Drucker W, Larson SM, J Clin Endocrinol Metab, 1/1/2006
• Recombinant Human TSH-Assisted Radioiodine Therapy For Patients with Metastatic Thyroid Cancer Who Could Not Elevated Endogenous TSH Or Be Withdrawn From Thyroxine  
  Driedger A, Magner J, Thyroid, 1/1/2006
• Diagnostic Accuracy and Prognostic Value of FDG-PET in Hürthle Cell Thyroid Cancer Patients  
  Pryma DA, Schöder H, Gönen M, Larson SM, Yeung HWD, J Nucl Med, 1/1/2006
• Serum Peptidome Patterns That Distinguish Metastatic Thyroid Carcinoma From Cancer-Free Controls Are Unbiased By Gender And Age  
  Villanueva J, Martorella AM, Lawlor K, Philip J, Fleisher M, Tempst P, Molecular and Cellular Proteomics, 1/1/2006
• Empiric Radioactive Iodine Dosing Regimens Frequently Exceed Maximum Tolerated Activity Levels In Elderly Patients With Thyroid Cancer  
  Tuttle RM, Leboeuf R, Qualey R, Pentlow K, Larson SM, Chan CY, J Nucl Med, 1/1/2006
• Update Of Newborn Screening And Therapy For Congenital Hypothyroidism  
  Rose, S.R., Brown, R.S., Foley, T., Kaplowitz, P.B., Kaye, C.I., Sundararajan, S., Varma, S.K., Brink, S.J., Clarke, W.L., Silverstein, J., Scales, R., Laskosz, L., Sc..., Pediatrics, 1/1/2006
• Correcting Common Errors in Identifying Serum Peptide Signatures of Solid Tumors  
  Villanueva J, Philip J, Chabarro C, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Tempst P, J Proteome Research, 1/1/2005
• Distilling cancer biomarkers from the serum peptidome: high technology reading of tea leaves or an insight to clinical systems biology?  
  Villanueva J, Tempst P, J Clinical Oncology, 1/1/2005
• The Evolving Role of 131-Iodine for the Treatment of Differentiated Thyroid Carcinoma  
  with Schlumberger M, J Nuclear Medicine, 1/1/2005
• Thyroid Carcinoma  
  Sherman SI, Angelos P, Ball DW, Beenken SW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR,..., J Natl Compr Canc Netw, 1/1/2005
• Growth Hormone (GH) Replacement Therapy in Adult-onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-blind, Randomized, Placebo-controlled Trial  
  Hoffman AR, Kuntze JE, Baptista, J, Baum, HB, Baumann, GP, Biller, BMK, Clark, RV, Cook, D, Inzucchi, SE, Kleinberg, D, Klibanski, A, Phillips, LS, Ridgway, EC, Schl..., J Clin Endocrinol Metab, 1/1/2004
• Factors influencing the basal and recombinant human TSH stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma  
  Srivastava, S, Shaha, A, Ghossein, R, Larson, SM, Fleisher, M, and Tuttle, RM, J Clin Endo Metab, 1/1/2004
• Patient specific dosimetry for 131-iodine thyroid cancer therapy using 124-iodine positron emission tomography and 3D-ID  
  Sgouros, G, Kolbert K, Sheikh A, Pentlow K, Mun E, Barth A, Larson SM, J Nucl Med, 1/1/2004
• Join now to see all

Books/Book Chapters

• MKSAP (Medical Knowledge Self-Assessment Program) 
  Chapter: Oncology, (Head and Neck Cancers; Thyroid Cancer) 
  Page 205 - 208Robbins RJAmerican Society of Clinical Oncology, Alexandria, VAEdition 3rd,2005
• Thyroid Cancer 
  Chapter: Papillary Microcarcinoma of the Thyroid 
  with Drucker WEditors: Mazzaferri E, ed.2005
• Advances in Molecular and Cellular Endocrinology 
  Chapter: The role of fluoro-deoxyglucose positron emission tomography (FDG-PET) in the management of differentiated thyroid cancer 
  Page 107 - 116Chan C, Tuttle RM, Larson SMEditors: Haugen B.Elsevier Publishers, Amsterdam, Netherlands2005
• Outline of Oncology Therapeutics 
  Chapter: Hypercalcemia of Malignancy 
  Page 189 - 192Mezitis, S., Adler, M., Haser, L.Editors: Ratain M, Tempero M., and Skosey C..W. B. Saunders Co., Philadelphia2001
• Clinical Endocrinology Update 2000 
  Chapter: Papillary Thyroid Carcinoma: Current Controversies and Practice Guidelines 
  Page 161 - 168Robbins, RJEditors: Mandel S..The Endocrine Society Press, Bethesda, MD2000
• Yale University School of Medicine Guide to Tests and Procedures 
  Chapter: Tests and Procedures Related to the Endocrine System 
  Robbins RJEditors: Zaret, B., Katz, L., and Jatlow, P..William Morrow, Inc., New York, NY1997
• Neurobase 
  Chapter: Prolactin Secreting Pituitary Tumors 
  Robbins RJEditors: Byrne, T..Arbor Publishing Corp.1995
• Neurobase 
  Chapter: Acromegaly 
  Robbins RJEditors: Byrne, T..Arbor Publishing Corp.1995
• Current Concepts in Medical Oncology 
  Chapter: Estrogens and Cancer 
  Robbins RJMemorial Sloan Kettering Cancer Center Publication1995
• Cellular and Molecular Approaches to the Treatment of Neurological Disease 
  Chapter: Cellular replacement of dopamine deficit in Parkinson’s disease using human fetal mesencephalic tissue: preliminary results in four patients 
  Page 325 - 359Redmond, D. E., Naftolin, F., Marek, K., Vollmer, T., Leranth, C., Roth, R., Price, L., Gjedde, A., Bunney, B., Sass, K., Elsworth, J., KIer, L., Makuch, R., Hoffer, P...Editors: Waxman, S..Raven Press, New York1993
• Molecular and Clinical Advances in Pituitary Disorders 
  Chapter: The Neurotrophic Activity of Insulin-like Growth Factor I on Hypothalamic Neurons 
  Rasmussen, J., and Torres-Aleman, IEditors: Melmed, S. and Robbins, R.Blackwell Publications1991
• Stress-induced alterations in neurotensin, somatostatin and corticotropin- releasing factor in mesotelencephalic dopamine system regions 
  Deutch, A., Bean, A., Bissette, G., Nemeroff, C., Roth, R1987
• Somatostatin 
  Chapter: Regulation of hypothalamic somatostatin secretion 
  Robbins, R.JEditors: Reichlin, S..Plenum Press1987
• Acromegaly 
  Robbins RJEditors: Robbins, R. and Melmed, S..Plenum Press1987
• Prolactinomas 
  Robbins RJEditors: Olefsky, J. and Robbins, R..Churchill-Livingston, New York, NY1986
• Current Medical Therapy 
  Chapter: Thyroid, parathyroid, adrenal, genital, and hypothalamo-pituitary disorders 
  Page 444 - 465Robbins, R.JEditors: Schrier, R.Raven Press1984
• Neuroendocrine Perspectives 
  Chapter: In vitro systems for secretion and synthesis of hypothalamic peptides 
  Page 111 - 136with Reichlin, SEditors: Muller, E.E. and MacLeod, R.M.Elsevier Biomedical Press1982
• Join now to see all

Other

• Guidelines for the Diagnosis and Management of Differentiated Thyroid Carcinoma 
  Robbins RJ, The PIER Project of the American College of Physicians
  www.acponline.org
  1/1/2001